צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים: Firefly Neuro (AIFF)

This chart on GURU.Markets illustrating the revenue trend over four quarters year-over-year shows that 162.80 represents the latest metric reading for Firefly Neuroscience, Inc (AIFF). Firefly Neuroscience, Inc generates revenue from cloud-based software for brain bioelectricity analysis in depression treatment. Growth is driven by the implementation of AI mapping in clinics, although slow adoption by psychiatrists and R&D expenses create certain risks.
פילוחי נתונים אנליטיים מרוכזים עבור Firefly Neuro (AIFF)

Firefly Neuroscience, Inc (AIFF) maintains its market defense through FDA certification of the Barriers platform and unique patents on neurodata. The year-over-year (TTM) sales growth captures the speed of revenue scaling via a rolling annual window, smoothing out quarterly fluctuations. Analysts compare this pace against the costs of integrating software into clinics. High expansion speed may temporarily reduce net income. The final business development trajectory is reflected in the year-over-year (TTM) sales growth.